5301 - 5325 of 6295 Results
Title
Year
-
OPENTitle: Levodopa Versus Dopamine Agonist after Subthalamic Stimulation in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 3Start Page: 672End Page: 680Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28382Best OA location URL: https://doi.org/10.1002/mds.28382Citation Count: 20
- Distinct spatiotemporal atrophy patterns in corticobasal syndrome are associated with different underlying pathologies2025OPENTitle: Distinct spatiotemporal atrophy patterns in corticobasal syndrome are associated with different underlying pathologiesJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 7Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcaf066Best OA location URL: https://doi.org/10.1093/braincomms/fcaf066Citation Count: 0
-
OPENTitle: Dynamic balance and gait impairments in Parkinson’s disease: novel cholinergic patternsJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 6Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcae286Best OA location URL: https://doi.org/10.1093/braincomms/fcae286Citation Count: 3
-
OPENTitle: Dystonia as complication of thalamic neurosurgeryJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 66Issue #:Start Page: 232End Page: 236Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.08.008Citation Count: 24
- Innovative Recruitment Strategies to Increase Diversity of Participation in Parkinson’s Disease Research: The Fox Insight Cohort Experience2020OPENTitle: Innovative Recruitment Strategies to Increase Diversity of Participation in Parkinson’s Disease Research: The Fox Insight Cohort ExperienceJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 2Start Page: 665End Page: 675Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-191901Best OA location URL: https://escholarship.org/uc/item/1rb4t3mzCitation Count: 48
- Executive functioning and risk-taking behavior in Parkinson’s disease patients with impulse control disorders2016OPENTitle: Executive functioning and risk-taking behavior in Parkinson’s disease patients with impulse control disordersJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 123Issue #: 6Start Page: 573End Page: 581Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00702-016-1549-yBest OA location URL: https://hal.sorbonne-universite.fr/hal-01311564Citation Count: 15
-
OPENTitle: GBA variation and susceptibility to multiple system atrophyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 77Issue #:Start Page: 64End Page: 69Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.007Best OA location URL: https://doi.org/10.1016/j.parkreldis.2020.06.007Citation Count: 20
- Capturing Differences in the Regulation of LRRK2 Dynamics and Conformational States by Small Molecule Kinase Inhibitors2023OPENTitle: Capturing Differences in the Regulation of LRRK2 Dynamics and Conformational States by Small Molecule Kinase InhibitorsJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 18Issue #: 4Start Page: 810End Page: 821Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschembio.2c00868Best OA location URL: https://escholarship.org/uc/item/9kp29910Citation Count: 13
- A Possible Novel Anti-Inflammatory Mechanism for the Pharmacological Prolyl Hydroxylase Inhibitor 3,4-Dihydroxybenzoate: Implications for Use as a Therapeutic for Parkinson’s Disease2012OPENTitle: A Possible Novel Anti-Inflammatory Mechanism for the Pharmacological Prolyl Hydroxylase Inhibitor 3,4-Dihydroxybenzoate: Implications for Use as a Therapeutic for Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2012Issue #:Start Page: 1End Page: 12Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/364684Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/364684.pdfCitation Count: 17
- Behavioral, neurochemical, and pathologic alterations in bacterial artificial chromosome transgenic G2019S leucine-rich repeated kinase 2 rats2014OPENTitle: Behavioral, neurochemical, and pathologic alterations in bacterial artificial chromosome transgenic G2019S leucine-rich repeated kinase 2 ratsJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 36Issue #: 1Start Page: 505End Page: 518Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.07.011Best OA location URL: https://uvadoc.uva.es/handle/10324/63882Citation Count: 47
- RETRACTED: ESCRT-mediated Uptake and Degradation of Brain-targeted α-synuclein Single Chain Antibody Attenuates Neuronal Degeneration In Vivo2014OPENTitle: RETRACTED: ESCRT-mediated Uptake and Degradation of Brain-targeted α-synuclein Single Chain Antibody Attenuates Neuronal Degeneration In VivoJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 22Issue #: 10Start Page: 1753End Page: 1767Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1038/mt.2014.129Best OA location URL: http://www.cell.com/article/S1525001616307808/pdfCitation Count: 82
-
OPENTitle: Red hair, MC1R variants, and risk for Parkinson's disease – a meta‐analysisJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 4Issue #: 3Start Page: 212End Page: 216Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.381Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.381Citation Count: 26
- Improving patient‐centred care for persons with Parkinson's: Qualitative interviews with care partners about their engagement in discussions of “off” periods2019OPENTitle: Improving patient‐centred care for persons with Parkinson's: Qualitative interviews with care partners about their engagement in discussions of “off” periodsJournal Name: Health ExpectationsPublisher: WileyVol: 22Issue #: 3Start Page: 555End Page: 564Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/hex.12884Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/hex.12884Citation Count: 20
-
OPENTitle: Mild cognitive impairment as a risk factor for Parkinson's disease dementiaJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 7Start Page: 1056End Page: 1065Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27002Best OA location URL: https://www.repository.cam.ac.uk/handle/1810/264547Citation Count: 145
- Longitudinal qualitative assessment of meaningful symptoms and relevance of WATCH-PD digital measures for people with early Parkinson’s2025OPENTitle: Longitudinal qualitative assessment of meaningful symptoms and relevance of WATCH-PD digital measures for people with early Parkinson’sJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 272Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-024-12789-0Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-024-12789-0.pdfCitation Count: 5
-
OPENTitle: Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's diseaseJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 480Issue #: 1Start Page: 78End Page: 82Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2010.06.009Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2943649Citation Count: 199
- Microglial Hv1 proton channel promotes cuprizone‐induced demyelination through oxidative damage2015OPENTitle: Microglial Hv1 proton channel promotes cuprizone‐induced demyelination through oxidative damageJournal Name: Journal of NeurochemistryPublisher: WileyVol: 135Issue #: 2Start Page: 347End Page: 356Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.13242Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.13242Citation Count: 63
- Bradykinesia and postural instability in a model of prodromal synucleinopathy with α-synuclein aggregation initiated in the gigantocellular nuclei2025OPENTitle: Bradykinesia and postural instability in a model of prodromal synucleinopathy with α-synuclein aggregation initiated in the gigantocellular nucleiJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1186/s40478-025-01948-7Best OA location URL: https://doi.org/10.1186/s40478-025-01948-7Citation Count: 0
- LRRK2 dynamics analysis identifies allosteric control of the crosstalk between its catalytic domains2022OPENTitle: LRRK2 dynamics analysis identifies allosteric control of the crosstalk between its catalytic domainsJournal Name: PLOS BiologyPublisher: Public Library of Science (PLoS)Vol: 20Issue #: 2Start Page: e3001427End Page: e3001427Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pbio.3001427Best OA location URL: https://doi.org/10.1371/journal.pbio.3001427Citation Count: 25
- 18F-flortaucipir PET to autopsy comparisons in Alzheimer’s disease and other neurodegenerative diseases2020OPENTitle: 18F-flortaucipir PET to autopsy comparisons in Alzheimer’s disease and other neurodegenerative diseasesJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 143Issue #: 11Start Page: 3477End Page: 3494Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awaa276Best OA location URL: https://academic.oup.com/brain/article-pdf/143/11/3477/36134848/awaa276.pdfCitation Count: 133
-
OPENTitle: Neuropsychological Test Performances and Depression in Early-Stage De Novo Parkinson’s DiseaseJournal Name: Archives of Clinical NeuropsychologyPublisher: Oxford University Press (OUP)Vol: 36Issue #: 1Start Page: 112End Page: 116Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/arclin/acz067Best OA location URL: https://academic.oup.com/acn/article-pdf/36/1/112/35858436/acz067.pdfCitation Count: 5
- Inactive S. aureus Cas9 downregulates alpha-synuclein and reduces mtDNA damage and oxidative stress levels in human stem cell model of Parkinson’s disease2023OPENTitle: Inactive S. aureus Cas9 downregulates alpha-synuclein and reduces mtDNA damage and oxidative stress levels in human stem cell model of Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-023-45078-3Best OA location URL: https://www.nature.com/articles/s41598-023-45078-3.pdfCitation Count: 8
-
OPENTitle: Genetic Testing in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 8Start Page: 1384End Page: 1396Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29500Best OA location URL: https://doi.org/10.1002/mds.29500Citation Count: 17
-
OPENTitle: BAG5 Inhibits Parkin and Enhances Dopaminergic Neuron DegenerationJournal Name: NeuronPublisher: Elsevier BVVol: 44Issue #: 6Start Page: 931End Page: 945Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neuron.2004.11.026Best OA location URL: http://www.cell.com/article/S0896627304007627/pdfCitation Count: 196
- 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes2022OPENTitle: 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytesJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 17Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-022-00551-xBest OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-022-00551-xCitation Count: 42